Related Experiment Videos
Management of the pediatric liver transplant patient
1University of California at Los Angeles Medical Center, Los Angeles, CA 90095, USA. smcdiarmid@mednet.ucla.edu
Insights
Optimizing pediatric liver transplant outcomes requires addressing malnutrition pre-transplant and managing technical complications like hepatic artery thrombosis post-transplant. Long-term care involves careful immunosuppression and monitoring for Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) and teen noncompliance.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Transplant Surgery
- Immunology
Background:
- Malnutrition significantly increases mortality risk in pediatric liver transplant candidates.
- Technical complications, especially hepatic artery thrombosis, are common in pediatric liver recipients due to small vessel size.
- Steroid-induced growth impairment necessitates early weaning in pediatric immunosuppression regimens.
Purpose of the Study:
- To outline essential pre- and post-transplant management strategies for pediatric liver recipients.
- To highlight key challenges including technical complications, immunosuppression side effects, and specific pediatric concerns.
- To emphasize the need for tailored approaches to optimize long-term outcomes and graft survival.
Main Methods:
- Review of critical management aspects in pediatric liver transplantation.
- Identification of common complications and risk factors.
- Discussion of strategies for prevention, early recognition, and intervention.
Main Results:
- Pretransplant malnutrition management is crucial for reducing mortality.
- Early detection of hepatic artery thrombosis is vital to prevent graft loss.
- Steroid weaning within the first year improves pediatric growth.
- Long-term immunosuppression requires monitoring for nephrotoxicity, neurotoxicity, malignancy, and infections.
- Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) requires specific prevention and management.
- Addressing noncompliance in adolescents is critical for graft and patient survival.
Conclusions:
- Comprehensive management addressing nutritional status, technical complications, and immunosuppression is essential for pediatric liver transplant success.
- Proactive strategies for EBV-associated PTLD and adolescent noncompliance are critical for long-term patient and graft survival.
- A multidisciplinary approach is necessary to navigate the complexities of pediatric liver transplantation and ensure optimal patient outcomes.
Abstract:
1. In pretransplant management, the prevention and treatment of malnutrition is essential for pediatric patients as malnutrition is associated with both increased pre- and posttransplant mortality. 2. Technical complications, particularly hepatic artery thrombosis, after pediatric liver transplantation are relatively common given the small size of the majority of the recipients. Early recognition is essential to reduce the associated increased risk for both patient and graft loss. 3. Immunosuppression regimens in children should aim to begin weaning of steroids within the first year after transplant because of their detrimental impact on growth. 4. Long-term immunosuppression strategies must focus on avoiding the risks of long-term immunosuppression, particularly nephrotoxicity, neurotoxicity, de novo malignancy, and late infections. 5. EBV-associated PTLD is a special problem for young pediatric liver recipients. Strategies for prevention and preemptive management are essential. 6. Noncompliance in teens is a particular problem and is associated not only with graft dysfunction, but also with graft loss and patient death. Recognizing teens at risk and providing intervention strategies require a multi-disciplinary approach.